Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients
Authors:
- Krystyna PawlakKPKrystyna Pawlak
- Dariusz PawlakDariusz Pawlak
- Michal MysliwiecMMMichal Mysliwiec
- 31 December 2007
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 120 (6) , 871-876
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesionsBlood Coagulation & Fibrinolysis, 2004
- Oxidative Stress – a Link between Endothelial Injury, Coagulation Activation, and Atherosclerosis in Haemodialysis PatientsAmerican Journal of Nephrology, 2004
- Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarctionBlood, 2002
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodialysis patientsAmerican Journal of Kidney Diseases, 1999
- UROKINASE PLASMINOGEN ACTIVATOR SYSTEM IN HUMANS WITH STABLE CORONARY ARTERY DISEASEClinical and Experimental Pharmacology and Physiology, 1999
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- Plasminogen Activator System in Human Coronary AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Urokinase receptors in human monocytesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990